CID 10445549

Galidesivir

Structural Information

Molecular Formula
C11H15N5O3
SMILES
C1=C(C2=C(N1)C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
InChI
InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1
InChIKey
AMFDITJFBUXZQN-KUBHLMPHSA-N
Compound name
(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

53
References

1912
Patents

265.1175 Da
Monoisotopic Mass

-2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 266.12478 158.8
[M+Na]+ 288.10672 167.8
[M-H]- 264.11022 156.3
[M+NH4]+ 283.15132 171.2
[M+K]+ 304.08066 161.7
[M+H-H2O]+ 248.11476 151.6
[M+HCOO]- 310.11570 172.4
[M+CH3COO]- 324.13135 168.0
[M+Na-2H]- 286.09217 158.9
[M]+ 265.11695 153.8
[M]- 265.11805 153.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe